Psychedelics Saves Lives: The Future of Psychopharmacology

“There are two great beings who invented psychedelics: God and Sasha Shulgin.” —James Fadiman. Would you take a pill that worked 80% or 20% of the time? Medicine was once viewed as what you were eating. People treated everything they put in their body as medicine.  All of your drugs in your medicine cabinet could potentially kill you if you take enough. Hell, water could kill you if you drank too much of it. Psychedelics have no LD 50 rate, meaning lethal dose for 50% of the human population, entheogens can’t and will never kill you, unless you jump out a 10-story window high on LSD.  A mouse tries cocaine in a water bottle, and every time they will do it repeatedly until it overdoses and dies. A mouse tries LSD in a water bottle once and never does it again. It (psychedelics) has the potential to cure: addiction, depression, anxiety, autism, PTSD, OCD, schizophrenia, bipolar disorder, etc. I was nearing the end of the year in 2016, in my intro psychology class, it was one of my last classes. In that class, we were talking about my favourite topic: drugs. At the end of the course, my teacher warned people not to do psilocybin mushrooms because she claimed it would make their brains bleed. This couldn’t be further away from the truth. In fact, magic mushrooms have been shown to expand the mind by growing and re-growing brain cells literally. I stayed a half-hour after class, referencing the many studies that have shown that psychedelics have been curing depression, anxiety, many types of addictions, and other mental health issues. Like the most effective therapies, people under the influence of psychedelics were put into an fMRI machine to scan their brains. It showed that both their conscious and unconscious mind were blended, lighting up all parts of the brain. It was like the awakening, and the REM sleep brain was working together. Just like Eye Movement Desterilization and Reprocessing (EMDR), Emotional Freedom Technique (EFT), Craniosacral Therapy (CST), Trauma-Sensitive Yoga (TSY), or people under hypnosis, they mesh your conscious and unconscious awareness together to help get over whatever it is you are dealing with, and or what don’t know what is bothering them, as it has been stuck in your unconscious mind. Those are just some of the over 100 therapies psychotherapists offer nowadays. Psychedelics brings it out of you instantaneously, especially those who are being guided through their session. That is why when people have a bad trip, they fail to recognize that your unconscious mind is trying to tell you something, and the more you ignore it, the worse the trip gets—some feel like there are about to die. Needless to say, that professor in the next class retracted her statement and now teaches her course the healing power of these beautiful substances. The co-founder of Alcoholics Anonymous (AA): Bill Wilson, is the non-profit support group for alcoholics and other substance abusers. AA itself helped cure Bill’s alcoholism in 1939. But, he still had debilitating depression, which almost drove him to suicide until the early 1950s. His one-night set-up by his father and the late great Aldous Huxley at the Veterans Administration hospital in Los Angeles cured his depression through LSD-assisted psychotherapy (back then, it was totally legal). Under Dr. Sidney Cohen’s supervision with Gerald Heard, a trusted spiritual mentor, as his guide, Bill had his first experience with LSD on August 29, 1956. After that time, Bill made it his goal to make LSD the 13th and final step of the AA 12-step program. He was quickly thrown out of AA, the fucking non-profit he started! He recognized back then that AA ignores the trauma side of things, which causes the addiction in the 1st place. LSD-assisted therapy cures and helps one deal with the trauma associated with their addiction. MDMA right now is getting fast tract through the FDA to make it legal for therapy. Thanks to one of my personal heroes: Alexander Shulgin, in the late 1970’s re-synthesized MDMA and said too many psychotherapists throughout the states that maybe you guys should look into this drug used with a guided psychotherapy session. Shulgin tried a new p every week for over 50 years up until his death at 88-years-old. He banked enough psychedelic drugs that he could easily replace all pharmaceutical drugs we use today, and they would be way better for us, with a hell of a lot fewer side effects. LSD was one of the first drugs ever adequately studied in the early 1950s. They quickly discovered serotonin as LSD mimics serotonin. Because of this discovery, we wouldn’t have the psyche meds we have today, or at least we wouldn’t have had them as fast as we did. In the late 1960’s James Fadiman, a psychologist took 48 people who were either scientists, architects, doctors of all sorts that we’re working on something within their field that hadn’t been yet figured out with a patent, product, math or science problem, and or a publication. Some people had been working on their complications for over 20 years. After one LSD therapy session: 44 of the 48 people figured out their problems. Never do psychedelic drugs unless under the supervision of a doctor/guide. It would be best if you had a babysitter. Suggested dosages: Heroic dose: Ethnobotanist Terrance Mckenna coined the term “heroic does,” which is often equated to 5 or more grams of mushrooms or more than 400 mcg LSD. This dose is not recommended. 400 mcg is where you have a transcendental or mystical experience. At this dose or higher, it is critical to have qualified supervision in the form of a guide. 200 mcg can be used for psychotherapy, self-exploration, deep inner work, and healing. 100 mcg is useful for creative problems solving with non-personal matters. Several Nobel Prize laureates in chemistry, biology, and elsewhere attribute breakthroughs to LSD If you have a predisposition to schizophrenia or bi-polar probably too fucked up on a results basis they don’t even have to try it because they seem like they’re on psychedelics as it is way too much as it is, probably should not partake in the experience, as that is there life. We one day may find a cure for it, though through psychedelics. Until that time, those who suffer severe mental illness or someone in their immediate family have it, and you should hold off for now. The many studies now involving people who are addicted to cancer-killing cigarettes and have them each a dose of mushrooms with a guided therapy session. After a year, on average: 67% of the participants abstained from smoking. Now comparing that to people who tried Chantix, which is the most helpful drug besides psychedelics, only helped as much as 20% of people quit smoking and Nicorette gum, or the nicotine patch, helped significantly fewer people. Ram Dass, formerly known as Richard Alpert, who quit being a professor along with Timothy Leary (remember from 1967 “Turn on, tune in, drop out?”), gave his Guru 600 micrograms Masha Riri who never had taken a psychedelic prior, asked for the most significant dose Ram Dass would give him, and Masha Riri began to go crazy, yelling and making all sorts of weird jesters, as Ram Dass started freaking out thinking oh my God! What have I done to my Guru! Then Riri began laughing, as it was all a big joke, and it literally didn’t affect him whatsoever. People can achieve the same altered states of consciousness through meditation/yoga/float tanks/etc. For me, it took about five years of solid meditation/yoga almost everyday practice, as well as utilizing float tanks, and Ibogaine helped speed up the ever so slow but well worth the practice. Suicide, depression, anxiety is growing exponentially. We haven’t had much going on with pharmaceuticals since the early 90’s to help treat these mental illnesses. So even the FDA is getting desperate to help treat the millions of people suffering around the world. In the Pineal gland in mice, they found it produced DMT. When dreaming, the brain makes DMT in humans. DMT is also grown throughout the body and nature. There are some cultures now, and many, many before us, don’t use psychedelics recreationally. They use it once a year, and if people use it outside of that, they are punished.   Here are some of the many studies going on to observe how effective psychedelics can positively be:
Alexander ‘Sasha’ Shulgin
  Studies: John Hopkins: Hallucinogenic drug found in ‘magic mushrooms’ eases depression, anxiety in people with life-threatening cancer. In a small double-blind study, Johns Hopkins researchers report that a substantial majority of people suffering cancer-related anxiety or depression found considerable relief for up to six months from a single large dose of psilocybin—the active compound in hallucinogenic “magic mushrooms.”   John Hopkins: Study explores the enduring positive, negative consequences of ingesting ‘magic mushrooms’ In a survey of almost 2,000 people who said they had a past negative experience when taking “magic mushrooms” containing the hallucinogen psilocybin, more than 10 percent said they believed their worst “bad trip” had put themselves or others in harm’s way, according to researchers at Johns Hopkins. A substantial majority of survey respondents called their most distressing episode one of the top 10 biggest challenges of their lives, though most also reported the experience to be “meaningful” or “worthwhile,” with half of these positive responses claiming it as one of the most valuable experiences in their life.   Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder After a hiatus of some 40 years, clinical research has resumed using classic hallucinogens to treat addiction. After completing a small open-label feasibility study, we are currently conducting a double-blind placebo-controlled clinical trial of psilocybin-assisted treatment of alcohol use disorder. Although treatment effects cannot be analyzed until the study is complete, descriptive case studies provide a useful window into the therapeutic process of psychedelic-assisted treatment of addiction. Here we describe three participants’ treatment trajectories in the ongoing trial to illustrate the range of experiences and persisting effects of psilocybin treatment. Although it is difficult to generalize from a few cases, several qualitative conclusions can be drawn from the data presented here. Although participants often find it difficult to describe much of their psilocybin experience, pivotal moments tend to be individualized, extremely vivid, and memorable. Often, the qualitative content extends beyond the clinical problem that is being addressed. The participants discussed in this paper experienced acute and lasting alterations in their perceptions of self, in the quality of their baseline consciousness, and their relationship with alcohol and drinking. In these cases, experiences of catharsis, forgiveness, self-compassion, and love were at least as salient as classic mystical content. Finally, feelings of increased “spaciousness” or mindfulness and increased control over choices and behaviour were reported following the drug administration sessions. Ultimately, the psilocybin-assisted treatment appears to elicit experiences that are extremely variable yet seem to meet the individual’s particular needs.   Long-term follow-up of psilocybin-facilitated smoking cessation.   All 15 participants completed a 12-month follow-up, and 12 (80%) returned for a long-term (≥16 months) follow-up, with a mean interval of 30 months (range = 16-57 months) between target-quit date (i.e., first psilocybin session) and long-term follow-up. At 12-month follow-up, 10 participants (67%) were confirmed as smoking abstinent. At long-term follow-up, nine participants (60%) were confirmed as smoking abstinent. At 12-month follow-up, 13 participants (86.7%) rated their psilocybin experiences among the five most personally meaningful and spiritually significant experiences of their lives. CONCLUSION: These results suggest that psilocybin holds considerable promise in promoting long-term smoking abstinence in the context of a structured treatment program. The present study adds to recent and historical evidence suggesting high success rates when using classic psychedelics in addiction treatment. Further research investigating the psilocybin-facilitated treatment of substance use disorders is warranted.   Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence.   Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.   Report on psychoactive drug use among adolescents using ayahuasca within a religious context.   Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up. “I am not here to build a business; I am not here to build a corporation; I am not here to build Schools; I am not here to build churches—I am no Mother Theresa. What I will do is—lead a legacy.” #FreeDemocracy #FightThePower

Leave a Reply

Your email address will not be published. Required fields are marked *